- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
Détention brevets de la classe A61K 31/137
Brevets de cette classe: 4620
Historique des publications depuis 10 ans
|
435
|
403
|
416
|
442
|
443
|
476
|
455
|
409
|
371
|
163
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Antecip Bioventures II LLC | 329 |
182 |
| Novartis AG | 10847 |
54 |
| The Regents of the University of California | 19898 |
51 |
| Grünenthal GmbH | 572 |
42 |
| Zogenix International Limited | 76 |
42 |
| The Procter & Gamble Company | 22016 |
38 |
| Nalpropion Pharmaceuticals LLC | 71 |
37 |
| Axsome Therapeutics, Inc. | 252 |
32 |
| Noven Pharmaceuticals, Inc. | 103 |
30 |
| Nevakar Injectables Inc. | 43 |
29 |
| Aquestive Therapeutics, Inc. | 179 |
25 |
| Gruenenthal GmbH | 101 |
24 |
| Pharnext | 91 |
23 |
| The Trustees of Columbia University in the City of New York | 3566 |
22 |
| Duke University | 3064 |
20 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2848 |
20 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2812 |
19 |
| Ironshore Pharmaceuticals & Development, Inc. | 35 |
19 |
| Kindeva Drug Delivery L.P., Kindeva GP II LLC, a Delaware limited liability company | 215 |
18 |
| Nova Southeastern University | 89 |
17 |
| Autres propriétaires | 3876 |